Polydopamine-coated ferric oxide nanoparticles for R848 delivery for photothermal immunotherapy in breast cancer.
Breast cancer
Fe(3)O(4) nanoparticles
Immunotherapy
Magnetic resonance imaging
Photothermal therapy
R848
Journal
International journal of pharmaceutics
ISSN: 1873-3476
Titre abrégé: Int J Pharm
Pays: Netherlands
ID NLM: 7804127
Informations de publication
Date de publication:
25 Sep 2023
25 Sep 2023
Historique:
received:
20
02
2023
revised:
02
07
2023
accepted:
17
07
2023
medline:
12
9
2023
pubmed:
20
7
2023
entrez:
19
7
2023
Statut:
ppublish
Résumé
Breast cancer, which requires comprehensive multifunctional treatment strategies, is a major threat to the health of women. To develop multifunctional treatment strategies, we combined photothermal therapy (PTT) with immunotherapy in multifunctional nanoparticles for enhancing the anti-tumor efficacy. Fe
Identifiants
pubmed: 37467816
pii: S0378-5173(23)00669-5
doi: 10.1016/j.ijpharm.2023.123249
pii:
doi:
Substances chimiques
polydopamine
0
ferric oxide
1K09F3G675
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
123249Informations de copyright
Copyright © 2023 Elsevier B.V. All rights reserved.
Déclaration de conflit d'intérêts
Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.